Q: Please describe this drug.
Constraint: The Molecule has the SMILES CCCNC[C@H](O)COc1ccccc1C(=O)CCc1ccccc1.
Answer: (S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCNC[C@H](O)COc1ccccc1C(=O)CCc1ccccc1
CCCNC[C@@H](COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
1-[2-[(2S)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one
Please describe this drug.
(S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).